CytoMed Therapeutics Limited
General ticker "GDTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $11.8M (TTM average)
CytoMed Therapeutics Limited does not follow the US Stock Market performance with the rate: -25.1%.
Estimated limits based on current volatility of 5.6%: low 0.75$, high 0.84$
Factors to consider:
- Total employees count: 42 (-2.3%) as of 2025
Short-term GDTC quotes
Long-term GDTC plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SGD0.00MM | SGD0.07MM | SGD0.32MM |
| Operating Expenses | SGD4.36MM | SGD3.67MM | SGD5.11MM |
| Operating Income | SGD-4.36MM | SGD-3.60MM | SGD-4.79MM |
| Non-Operating Income | SGD0.23MM | SGD1.08MM | SGD0.79MM |
| Interest Expense | SGD0.05MM | SGD0.02MM | SGD0.02MM |
| R&D Expense | SGD0.00MM | SGD1.91MM | SGD2.22MM |
| Income(Loss) | SGD-4.13MM | SGD-2.52MM | SGD-4.00MM |
| Taxes | SGD0.00MM | SGD0.00MM | SGD0.00MM |
| Net Income(Loss)* | SGD-4.13MM | SGD-2.52MM | SGD-3.98MM |
| Stockholders Equity | SGD11.28MM | SGD8.96MM | SGD6.54MM |
| Inventory | SGD0.68MM | SGD0.84MM | SGD1.07MM |
| Assets | SGD12.40MM | SGD10.07MM | SGD7.98MM |
| Operating Cash Flow | SGD-3.54MM | SGD-2.71MM | SGD-3.70MM |
| Capital expenditure | SGD0.06MM | SGD1.40MM | SGD0.70MM |
| Investing Cash Flow | SGD-2.73MM | SGD1.13MM | SGD0.93MM |
| Financing Cash Flow | SGD10.92MM | SGD-0.06MM | SGD0.21MM |
| Earnings Per Share** | SGD-0.39 | SGD-0.22 | SGD-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.